Streetbeat News

Products Services

SYRS

Syros Pharmaceuticals has been granted Fast Track designation by the FDA for Tamibarotene, aimed at treating newly diagnosed unfit AML patients with RARA gene overexpression. This designation could expedite the development and review process for Tamibarotene, potentially bringing it to market quicker.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 11:10 am

TRAK

ReposiTrak, a key player in the food traceability network, has expanded its network by adding 20 new suppliers. This expansion is part of its ongoing efforts to enhance food safety and traceability across the supply chain.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 11:07 am

BMY

TSVT

The FDA has approved the use of a suspension lentiviral vector for the manufacturing of Abecma, as announced by 2Seventy Bio and Bristol Myers Squibb. This approval marks a significant advancement in the production process of Abecma.

Portfolio Pulse from Charles Gross

April 09, 2024 | 11:06 am

IRDM

LHX

Iridium has signed a new five-year commercial contract with L3Harris Technologies to provide Iridium Satellite Time and Location (STL) service. This service will be provided to over three dozen L3Harris-operated communications network backbone nodes and a similar number of Federal Aviation Administration (FAA) facilities across the United States.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 11:05 am

MITK

DataVisor has announced a partnership with Mitek Systems (MITK) to enhance its fraud detection ecosystem with improved check fraud protection capabilities. This collaboration aims to leverage Mitek's advanced technology to bolster DataVisor's existing fraud detection solutions, providing clients with more robust protection against check fraud.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 11:05 am

GOOG

GOOGL

Google is expanding its in-house chip development efforts to better compete in the rapidly growing AI sector. This move is part of a broader trend among tech companies to create custom hardware tailored for AI applications, which require significant computational power. Google's initiative, which began in 2016, aims to produce bespoke hardware to enhance its AI capabilities and efficiency.

Portfolio Pulse from Charles Gross

April 09, 2024 | 11:03 am

ALKS

Alkermes announced positive topline results from its Phase 1b study of ALKS 2680, a treatment for patients with Narcolepsy Type 2 and Idiopathic Hypersomnia. This marks a significant milestone in the development of a potential new treatment option for these sleep disorders.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 11:03 am

GOGO

Gogo has received FCC regulatory approval for its Gogo Galileo Terminals, with plans to begin flight testing this summer on its Challenger 300 testbed. The HDX terminal is expected to be certified and commercially launched later this year.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 11:03 am

EVGO

EVgo has expanded its Autocharge+ service to support over 50 electric vehicle models, enhancing the charging experience by allowing drivers to start charging sessions without needing a mobile app or RFID card. This expansion could significantly improve user convenience and potentially increase the usage of EVgo's charging network.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 11:02 am

NRIX

SNY

Nurix Therapeutics and Sanofi have extended their ongoing research program focused on STAT6, a key target in type 2 inflammation. The original agreement, signed in December 2019, included an upfront payment of $55 million from Sanofi, with an additional $22 million paid later to expand the collaboration. Nurix could receive up to $2.5 billion in future milestones and royalties. The extension aims to nominate a clinical candidate within the first year.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 11:02 am